Radnostix Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting a net loss of $842,242 for the third quarter and $3,072,325 for the nine months ended September 30, 2026.

Key Highlights

  • Q3 2026 revenue declined: Product sales were $2,571,035 for the three months ended September 30, 2026, compared with $3,277,816 for the same period in 2025, according to the filing.
  • Nine-month net loss widened: The company reported a net loss of $3,072,325 for the nine months ended September 30, 2026, versus a net loss of $477,080 for the comparable 2025 period.
  • Accumulated deficit grew: The accumulated deficit stood at $131,301,612 as of September 30, 2026, up from $128,229,287 at December 31, 2025.
  • Cash position decreased: Cash and cash equivalents were $711,288 at September 30, 2026, down from $1,695,158 at December 31, 2025.
  • Shares outstanding increased: As of November 16, 2026, there were 542,145,510 shares of common stock, $0.01 par value, outstanding, compared with 528,209,538 at December 31, 2025.
  • Related party notes payable rose: Related party notes payable were $2,120,000 at September 30, 2026, up from $1,620,000 at December 31, 2025.

Radnostix Reports Steeper Losses and Lower Revenue Through September 2026

Radnostix Inc. (OTC:INIS), a smaller reporting company incorporated in Texas and headquartered in Idaho Falls, Idaho, disclosed in its quarterly report that product sales for the three months ended September 30, 2026 totaled $2,571,035, a decrease from $3,277,816 in the year-earlier quarter. Gross profit for the third quarter was $1,514,215, compared with $1,940,019 for the same period in 2025. Total operating expenses for the quarter were $2,297,254, resulting in a net operating loss of $783,039, the filing stated.

For the nine months ended September 30, 2026, the company reported total product sales of $7,621,744, down from $10,172,036 in the first nine months of 2025. Total operating expenses for the nine-month period were $6,951,718, against gross profit of $4,024,398, producing a net operating loss of $2,927,320. After other expense of $145,005, the net loss for the nine-month period was $3,072,325, compared with a net loss of $477,080 in the prior-year period, according to the filing.

On the balance sheet, total assets were $16,854,943 as of September 30, 2026, compared with $17,836,632 at December 31, 2025. Total liabilities increased to $14,927,722 from $14,143,885 over the same period. The company disclosed that cash used in operating activities for the nine months ended September 30, 2026 was $1,132,543, while net cash used in investing activities was $205,570. Financing activities provided $394,749 in net cash, including $500,000 from proceeds from the issuance of notes payable. The filing also noted a noncash transaction in which property was acquired in exchange for the issuance of stock valued at $750,000.

What Was Disclosed

Radnostix Inc. filed its quarterly report covering the period ended September 30, 2026, disclosing lower product revenue, a wider net loss, reduced cash balances, a higher accumulated deficit, and an increase in related party notes payable compared with year-end 2025 figures.